IFNGR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.158600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.460430E-02
Normal-vs-Stage2
1.541270E-03
Normal-vs-Stage3
3.022000E-02
Normal-vs-Stage4
1.121370E-01
Stage1-vs-Stage2
3.047000E-01
Stage1-vs-Stage3
9.537400E-01
Stage1-vs-Stage4
3.878400E-01
Stage2-vs-Stage3
4.342400E-01
Stage2-vs-Stage4
7.772800E-01
Stage3-vs-Stage4
4.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.374800E-04
Normal-vs-AfricanAmerican
7.830000E-02
Normal-vs-Asian
4.775200E-03
Caucasian-vs-AfricanAmerican
2.839400E-01
Caucasian-vs-Asian
4.595400E-01
AfricanAmerican-vs-Asian
1.745750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.392100E-04
Normal-vs-Female
3.637100E-03
Male-vs-Female
2.505900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.328300E-02
Normal-vs-Age(41-60Yrs)
1.163770E-03
Normal-vs-Age(61-80Yrs)
1.019770E-03
Normal-vs-Age(81-100Yrs)
8.338900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.277200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.110400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.483000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.470400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.218600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.881400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.408700E-04
Normal-vs-Daily Drinker
5.796500E-03
Normal-vs-Weekly Drinker
2.312000E-02
Normal-vs-Occasional Drinker
3.915400E-03
Normal-vs-Social Drinker
2.983900E-03
Non Drinker-vs-Daily Drinker
9.675200E-01
Non Drinker-vs-Weekly Drinker
4.796400E-01
Non Drinker-vs-Occasional Drinker
4.749200E-01
Non Drinker-vs-Social Drinker
3.484400E-01
Daily Drinker-vs-Weekly Drinker
5.327200E-01
Daily Drinker-vs-Occasional Drinker
5.255200E-01
Daily Drinker-vs-Social Drinker
4.142000E-01
Weekly Drinker-vs-Occasional Drinker
9.219000E-01
Weekly Drinker-vs-Social Drinker
9.336200E-01
Occasional Drinker-vs-Social Drinker
8.223800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.773000E-01
Normal-vs-Grade 2
5.196400E-02
Normal-vs-Grade 3
8.598400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.395800E-02
Grade 1-vs-Grade 3
2.301800E-01
Grade 1-vs-Grade 4
2.773000E-01
Grade 2-vs-Grade 3
2.438800E-01
Grade 2-vs-Grade 4
5.196400E-02
Grade 3-vs-Grade 4
8.598400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.551300E-04
Normal-vs-NonDiabetic
9.022600E-04
Diabetic-vs-NonDiabetic
2.766200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.016800E-03
Normal-vs-NoPancreatitis
8.819700E-04
Pancreatitis-vs-NoPancreatitis
8.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.441600E-04
Normal-vs-N1
1.757760E-03
N0-vs-N1
7.362400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.198500E-04
Normal-vs-TP53-NonMutant
6.717200E-03
TP53-Mutant-vs-TP53-NonMutant
4.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
